abstract |
(57) Summary The present invention relates to pharmaceutical compositions useful for treating allergic rhinitis, asthma, and related disorders. In one embodiment, the composition comprises at least one neurokinin antagonist therapeutically effective amount of at least one H 3 antagonist therapeutically effective amount, and a combination of at least one of an H 1 antagonist therapeutically effective amount. |